X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-15 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $25.61 | -714 | 77,357 | -1% | -$18,286 | ||||||
2025-09-15 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.16 | +2,068,453 | 20,708,548 | +11% | +$2,400,001 | ||||||
2025-09-16 | AXGN | Axogen, Inc. | Devinney Erick Wayne | Chief Innovation Officer | S - Sale | $16.29 | -1,137 | 220,649 | -1% | -$18,522 | ||||||
| M | 2025-07-25 | STEX | Streamex Corp. | Giustra Frank | 10% | P - Purchase | $4.12 | +178,205 | 178,205 | New | +$734,725 | |||||
2025-09-11 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $26.83 | -511 | 193,672 | 0% | -$13,710 | ||||||
2025-09-11 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $26.83 | -630 | 351,421 | 0% | -$16,903 | ||||||
2025-09-11 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $26.83 | -1,032 | 184,186 | -1% | -$27,689 | ||||||
2025-09-11 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $26.83 | -358 | 133,906 | 0% | -$9,605 | ||||||
2025-09-11 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $26.83 | -233 | 78,071 | 0% | -$6,251 | ||||||
2025-09-11 | BLFS | Biolife Solutions Inc | Werner Sean | CTO | S - Sale | $26.83 | -72 | 26,312 | 0% | -$1,932 | ||||||
2025-09-12 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.36 | +1,450 | 61,950 | +2% | +$1,975 | ||||||
2025-09-12 | CNMD | Conmed Corp | Farkas Charles | Dir | S - Sale | $53.52 | -2,000 | 14,859 | -12% | -$107,049 | ||||||
| M | 2025-09-10 | ELMD | Electromed, Inc. | Summers Andrew | Dir | S - Sale | $24.32 | -65,714 | 282,420 | -19% | -$1,598,454 | |||||
2025-09-11 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.35 | +1,250 | 60,500 | +2% | +$1,682 | ||||||
2025-09-10 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.34 | +1,500 | 59,250 | +3% | +$2,010 | ||||||
2025-09-09 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.37 | +1,500 | 57,750 | +3% | +$2,055 | ||||||
2025-09-08 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.40 | +500 | 56,250 | +1% | +$700 | ||||||
| D | 2025-09-04 | CBLL | Ceribell, Inc. | Woo Raymond | CTO | S - Sale+OE | $12.11 | -11,112 | 167,704 | -6% | -$134,566 | |||||
2025-09-05 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.35 | +1,000 | 55,750 | +2% | +$1,350 | ||||||
| D | 2025-08-29 | GTHP | Guided Therapeutics Inc | Grujic Alan | Dir | P - Purchase | $0.00 | +152,108 | 1,817,541 | +9% | +$0 | |||||
2025-09-03 | MDT | Medtronic Plc | Kiil Harry Skip | EVP, Pres Cardiovascular | S - Sale | $91.58 | -8,605 | 35,615 | -19% | -$788,048 | ||||||
| D | 2025-08-29 | GTHP | Guided Therapeutics Inc | Imhoff John E | Dir, 10% | P - Purchase | $0.18 | +166,667 | 19,463,595 | +1% | +$30,000 | |||||
2025-09-03 | CBLL | Ceribell, Inc. | Robertson Rebecca B | Dir | S - Sale | $11.36 | -827 | 9,215 | -8% | -$9,395 | ||||||
| D | 2025-08-29 | GTHP | Guided Therapeutics Inc | James Michael C | Dir | P - Purchase | $0.18 | +27,778 | 553,495 | +5% | +$5,000 | |||||
2025-09-04 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.36 | +1,125 | 54,750 | +2% | +$1,531 | ||||||
2025-09-03 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.36 | +625 | 53,625 | +1% | +$850 | ||||||
2025-09-02 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.34 | +625 | 53,000 | +1% | +$838 | ||||||
2025-08-29 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.37 | +625 | 52,375 | +1% | +$856 | ||||||
2025-08-27 | CBLL | Ceribell, Inc. | Foehr David | SVP, Finance, PAO | S - Sale | $11.71 | -866 | 20,250 | -4% | -$10,141 | ||||||
2025-08-28 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.35 | +1,005 | 51,750 | +2% | +$1,356 | ||||||
2025-08-26 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $25.44 | -531 | 352,051 | 0% | -$13,509 | ||||||
2025-08-26 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $25.44 | -413 | 194,183 | 0% | -$10,507 | ||||||
2025-08-26 | BLFS | Biolife Solutions Inc | Werner Sean | CTO | S - Sale | $25.44 | -111 | 26,384 | 0% | -$2,824 | ||||||
2025-08-26 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $25.44 | -590 | 185,218 | 0% | -$15,010 | ||||||
2025-08-26 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $25.44 | -219 | 78,304 | 0% | -$5,571 | ||||||
2025-08-26 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $25.44 | -354 | 134,264 | 0% | -$9,006 | ||||||
2025-08-27 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.28 | +1,000 | 50,745 | +2% | +$1,283 | ||||||
2025-08-25 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $25.53 | -10,000 | 124,618 | -7% | -$255,300 | ||||||
2025-08-25 | LIVN | Livanova Plc | Bianchi Francesco | Dir | S - Sale | $56.50 | -1,500 | 9,028 | -14% | -$84,750 | ||||||
2025-08-26 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.26 | +1,000 | 49,745 | +2% | +$1,258 | ||||||
| D | 2025-08-25 | SMLR | Semler Scientific, Inc. | Murphy-Chutorian Douglas | CEO | S - Sale+OE | $30.54 | -28,604 | 186,709 | -13% | -$873,566 | |||||
2025-08-25 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.25 | +1,000 | 48,745 | +2% | +$1,245 | ||||||
| M | 2025-08-22 | MDT | Medtronic Plc | Jellison William R | Dir | P - Purchase | $92.55 | +5,000 | 5,000 | New | +$462,750 | |||||
2025-08-22 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.22 | +1,000 | 47,745 | +2% | +$1,220 | ||||||
2025-08-21 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.25 | +2,000 | 46,745 | +4% | +$2,490 | ||||||
2025-08-15 | BLFS | Biolife Solutions Inc | Casdin Partners Master Fund, L.P. | 10% | S - Sale | $24.40 | -500,000 | 6,707,165 | -7% | -$12,200,000 | ||||||
2025-08-19 | CBLL | Ceribell, Inc. | Taylor Joseph Michael | Dir | S - Sale | $11.76 | -7,032 | 59,235 | -11% | -$82,696 | ||||||
2025-08-20 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.18 | +1,000 | 44,745 | +2% | +$1,184 | ||||||
2025-08-19 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.17 | +3,000 | 43,745 | +7% | +$3,499 | ||||||
2025-08-18 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $1.18 | +12,024 | 300,000 | +4% | +$14,229 | ||||||
2025-08-18 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.18 | +1,500 | 40,745 | +4% | +$1,767 | ||||||
2025-08-15 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.17 | +1,500 | 39,245 | +4% | +$1,755 | ||||||
2025-08-18 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $1.33 | -1,151 | 381,062 | 0% | -$1,531 | ||||||
2025-08-15 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $12.88 | -904 | 164,578 | -1% | -$11,644 | ||||||
2025-08-15 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $12.88 | -243 | 42,898 | -1% | -$3,130 | ||||||
2025-08-15 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $12.88 | -383 | 46,883 | -1% | -$4,933 | ||||||
| M | 2025-08-12 | MASI | Masimo Corp | Brennan Michelle | Chairman of the Board | P - Purchase | $152.80 | +200 | 7,318 | +3% | +$30,560 | |||||
2025-08-11 | BLFS | Biolife Solutions Inc | Casdin Partners Master Fund, L.P. | 10% | S - Sale | $22.60 | -500,000 | 7,207,165 | -6% | -$11,300,000 | ||||||
2025-08-11 | ECOR | Electrocore, Inc. | Errico Thomas J. | Dir | P - Purchase | $4.47 | +15,000 | 281,401 | +6% | +$67,050 | ||||||
2025-08-11 | MASI | Masimo Corp | Jellison William R | Dir | P - Purchase | $145.98 | +3,000 | 4,790 | +168% | +$437,940 | ||||||
2025-08-11 | ECOR | Electrocore, Inc. | Goldberger Daniel S | CEO | P - Purchase | $4.23 | +1,000 | 291,565 | 0% | +$4,230 | ||||||
| M | 2025-08-06 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | P - Purchase | $117.46 | +16,875 | 607,658 | +3% | +$1,982,121 | |||||
2025-08-07 | CNMD | Conmed Corp | Garner Todd W | EVP, CFO | S - Sale | $52.45 | -598 | 0 | -100% | -$31,365 | ||||||
| D | 2025-08-04 | TMDX | Transmedics Group, Inc. | Basile Edward M | Dir | S - Sale+OE | $125.51 | -4,143 | 2,866 | -59% | -$519,988 | |||||
2025-07-18 | BLFS | Biolife Solutions Inc | Werner Sean | CTO | S - Sale | $21.22 | -1,115 | 26,495 | -4% | -$23,660 | ||||||
2025-07-07 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $22.27 | -198 | 78,523 | 0% | -$4,409 | ||||||
2025-07-07 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $22.27 | -400 | 194,596 | 0% | -$8,908 | ||||||
2025-07-07 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $22.27 | -877 | 185,808 | 0% | -$19,531 | ||||||
2025-07-07 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $22.27 | -536 | 352,582 | 0% | -$11,937 | ||||||
2025-07-07 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $22.27 | -304 | 134,618 | 0% | -$6,770 | ||||||
| D | 2025-07-07 | CBLL | Ceribell, Inc. | Chao Xingjuan | Pres, CEO | S - Sale+OE | $17.70 | -25,000 | 1,145,110 | -2% | -$442,500 | |||||
| D | 2025-07-01 | NRXS | Neuraxis, Inc | Masimo Corp | 10% | S - Sale+OE | $2.25 | -821,327 | 0 | -100% | -$1,847,986 | |||||
2025-07-01 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | SEE REMARKS | S - Sale | $82.76 | -3,830 | 13,206 | -22% | -$316,971 | ||||||
2025-07-01 | NRX | Neuraxis, Inc | Hannasch Brian | 10% | P - Purchase | $2.25 | +355,556 | 1,131,522 | +46% | +$800,001 | ||||||
| D | 2025-06-24 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | SEE REMARKS | S - Sale+OE | $84.25 | -266 | 17,036 | -2% | -$22,411 | |||||
| M | 2025-06-17 | CBLL | Ceribell, Inc. | Robertson Rebecca B | Dir | S - Sale | $17.76 | -18,633 | 10,042 | -65% | -$330,961 | |||||
2025-06-16 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $22.23 | -711 | 78,721 | -1% | -$15,806 | ||||||
| D | 2025-06-16 | CBLL | Ceribell, Inc. | Robertson Rebecca B | Dir | S - Sale+OE | $17.14 | -20,000 | 28,675 | -41% | -$342,800 | |||||
2025-06-13 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $0.97 | +20,000 | 287,976 | +7% | +$19,372 | ||||||
2025-06-13 | IRIX | Iridex Corp | Mercer Patrick | Pres, CEO | P - Purchase | $0.96 | +250 | 386,730 | 0% | +$240 | ||||||
| M | 2025-06-11 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $0.97 | +30,000 | 267,976 | +13% | +$29,121 | |||||
2025-06-10 | BLFS | Biolife Solutions Inc | Casdin Partners Master Fund, L.P. | 10% | S - Sale | $23.80 | -1,000,000 | 7,707,165 | -11% | -$23,800,000 | ||||||
2025-06-10 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $23.70 | -362 | 134,922 | 0% | -$8,579 | ||||||
2025-06-10 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $23.70 | -637 | 353,118 | 0% | -$15,097 | ||||||
2025-06-10 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $23.70 | -1,042 | 186,685 | -1% | -$24,695 | ||||||
2025-06-10 | BLFS | Biolife Solutions Inc | Werner Sean | CTO | S - Sale | $23.70 | -65 | 27,610 | 0% | -$1,541 | ||||||
2025-06-10 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $23.70 | -235 | 79,432 | 0% | -$5,570 | ||||||
2025-06-10 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $23.70 | -320 | 194,996 | 0% | -$7,584 | ||||||
2025-06-11 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.97 | +245 | 15,245 | +2% | +$236 | ||||||
2025-06-09 | AXGN | Axogen, Inc. | Weiler Kathy Johnson | Dir | S - Sale | $10.61 | -4,073 | 6,580 | -38% | -$43,215 | ||||||
2025-06-09 | AXGN | Axogen, Inc. | Levine Alan M | Dir | S - Sale | $10.61 | -4,073 | 36,743 | -10% | -$43,215 | ||||||
2025-06-09 | AXGN | Axogen, Inc. | Wendell Amy McBride | Dir | S - Sale | $10.61 | -4,073 | 93,826 | -4% | -$43,215 | ||||||
2025-06-09 | AXGN | Axogen, Inc. | Burke William P. Mr. | Dir | S - Sale | $10.61 | -4,073 | 24,484 | -14% | -$43,215 | ||||||
2025-06-09 | AXGN | Axogen, Inc. | Neels Guido J | Dir | S - Sale | $10.61 | -4,073 | 86,743 | -4% | -$43,215 | ||||||
2025-06-09 | AXGN | Axogen, Inc. | Johnson John | Dir | S - Sale | $10.61 | -4,073 | 24,943 | -14% | -$43,215 | ||||||
| D | 2025-06-10 | AXGN | Axogen, Inc. | Tyndall Joseph A. | Dir | S - Sale+OE | $10.72 | -26,931 | 0 | -100% | -$288,700 | |||||
| M | 2025-06-09 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.98 | +835 | 15,000 | +6% | +$822 | |||||
2025-06-09 | TMDX | Transmedics Group, Inc. | Ranganath Anil P. | See remarks | S - Sale | $139.80 | -686 | 13,955 | -5% | -$95,903 | ||||||
2025-06-06 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.97 | +1,500 | 14,165 | +12% | +$1,455 | ||||||
| D | 2025-06-05 | ITGR | Integer Holdings Corp | Maxwell Martin C | Dir | S - Sale+OE | $120.56 | -8,720 | 22,170 | -28% | -$1,051,279 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |